Short answer
Stereotaxis, Inc. (STXS) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Section 2.02 text contains only a standard exhibit-disclaimer provision.
Stereotaxis, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Section 2.02 text contains only a standard exhibit-disclaimer provision
- No operating results or financial metrics are included; investor focus should shift to the referenced exhibit, if filed
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $7.7M, down from $8.8M, as system revenue fell to $1.5M from $3.0M
- Recurring revenue rose to $6.2M, with robotic catheter revenue exceeding $1M and growing 270% sequentially
- Gross margin 58%; recurring revenue margin 66% versus system margin 29%, highlighting higher-value consumables economics
- Net loss widened to $4.5M from $3.8M; negative free cash flow remained $3.7M
- Cash $10.5M with no debt; recurring revenue guided to $7M in Q3 and $8M in Q4, with cash-flow profitability targeted for first-half 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Stereotaxis, Inc. 8-K filings
Get the next STXS 8-K as it lands
Follow STXS for push alerts, or ask the research agent what this filing means.